Results 151 to 160 of about 43,229 (277)

Global policy and access to new hepatitis C therapies for people who inject drugs [PDF]

, 2015
Aspinall, Esther, Doyle, Joseph S., Gore, Charles, Hellard, Margaret E., Hutchinson, Sharon, Quinn, Brendan, Wiktor, Stefan   +6 more
core   +1 more source

Treatment of Hepatitis C Virus Infection in the HIV- Infected Patients by Pegylated Interferon and Ribavirin in Tehran, Iran

, 2017
Ali Pashaei Zanjani, N Esmaeilpour, Mehrnaz Rasoolinejad, Pardis Moradnejad, Mojtaba Hedayat Yaghoobi   +4 more
openalex   +1 more source

Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea [PDF]

, 2012
Hyeong Il Kim, In Hee Kim, Byung Jun Jeon, Seok Lee, Seong‐Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, Dae Ghon Kim   +8 more
openalex   +1 more source

Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. [PDF]

Hepatol Int
Dong J, Ren S, Wu P, Yu H, Meng X, Zhao J, Ye X, Huang Y, Yu Z, Zhang W, Zeng Y, Wang X, Gao H, Dang S, Li J, Zheng S, Chen X.   +16 more
europepmc   +1 more source

The impact of JAK2^V617F variant allele frequency in MPN patients following PEGylated interferon alpha discontinuation. [PDF]

Br J Haematol
Brown R, Bennett R, Crean C, Hindley A, McGimpsey J, Cunningham N, Niblock A, McPherson S, Boyd K, Foy A, Graham C, Greenfield G, McMullin MF, Catherwood MA.   +13 more
europepmc   +1 more source

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment [PDF]

, 2017
Genglin Zhang, Youming Chen, Ting Zhang, Qingxian Cai, Xiaohong Zhang, Zhixing Zhao, Chaoshuang Lin, Zhiliang Gao   +7 more
openalex   +1 more source

The impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of pegylated interferon-based therapy in patients with chronic hepatitis B. [PDF]

Front Immunol
Han J, Xu L, Li Y, Wang Z, Zeng M, Gao J, Mi Y, Kuai W, Xiang H, Xu L.   +9 more
europepmc   +1 more source

Oxidative status and the response to pegylated-interferon alpha2A plus ribavirin in chronic genotype 4 HCV hepatitis

, 2013
Mohammed Mahmound Ahmed, Omar M. E. Abdel‐Salam, Nadia A. Mohammed, Dawoud Fakhry Habib, Howayda E. Gomaa   +4 more
openalex   +2 more sources

Predictors of low-level viremia in chronic hepatitis B and the efficacy of pegylated interferon-alpha: a real-world study. [PDF]

Virol J
Zhang W, Chen J, Sun W, Xie N, Tian F, Zhang W, Ruan Q, Song J.   +7 more
europepmc   +1 more source

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection. [PDF]

Acta Derm Venereol, 2023
Gosmann J, Stadler R, Quint KD, Gutzmer R, Vermeer MH.   +4 more
europepmc   +1 more source